๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of androgen receptors in benign and malignant endometrial stromal neoplasms

โœ Scribed by Farid Moinfar; Peter Regitnig; AliDastranj Tabrizi; Helmut Denk; FattanehA. Tavassoli

Publisher
Springer
Year
2004
Tongue
English
Weight
361 KB
Volume
444
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neuroendocrine cells in benign and malig
Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status
โœ Bonkhoff, Helmut ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 283 KB ๐Ÿ‘ 2 views

BACKGROUND. The presence of neuroendocrine (NE) differentiation in benign and neoplastic prostate tissue has attracted increasing attention in contemporary prostate cancer research. METHODS. The present review focuses on the proliferation and androgen receptor (AR) status of NE phenotypes and their

Frequency and degree of aneuploidy in be
Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms
โœ Lodewijk J. D. M. Schelfhout; Cees J. Cornelisse; Bernard M. Goslings; Jacob F. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 537 KB

The frequency and degree of aneuploidy in 44 benign and I24 malignant thyroid neoplasms were analyzed by DNA flow cytometry. Single aneuploid cell populations were found in 72% of the undifferentiated carcinomas, 64% of the follicular carcinomas, 24% of the papillary carcinomas and in 24% of the fol

CD44 expression in benign, premalignant,
CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression
โœ Saegusa, Makoto; Machida, Daisuke; Hashimura, Miki; Okayasu, Isao ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB ๐Ÿ‘ 2 views

To clarify the possible role of CD44 expression in ovarian tumour development and progression, an immunohistochemical investigation was undertaken of a series of 115 carcinomas, 32 tumours with low malignant potential (LMP), and 53 cystadenomas. A combination of the reverse transcription-polymerase